You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Multiple Myeloma Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 4 of 4

A phase III trial to combine the effects of a group of medications with another combination in patients with newly diagnosed Symptomatic Multiple Myeloma

This randomized phase III trial studies lenalidomide, dexamethasone, and bortezomib to see how well it works compared to dexamethasone and lenalidomide alone in treating patients with previously untreated multiple myeloma.
Cancer - Leukemia, Cancer, Cancer - Multiple Myeloma

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

ENDURANCE Trail for Patients with Newly Diagnosed Symptomatic Multiple Myeloma

This study compares the effects of two different drug combinations on patients with newly diagnosed multiple myeloma.
Cancer, Cancer - Multiple Myeloma

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Molecular Analysis for Therapy Choice (MATCH)

Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (DART)

Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA   

Recruiting
Page 1 of 1 | Results 1 - 4 of 4